<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00403767</url>
  </required_header>
  <id_info>
    <org_study_id>CR012157</org_study_id>
    <secondary_id>39039039AFL3001</secondary_id>
    <secondary_id>ROCKET AF</secondary_id>
    <secondary_id>2006-004595-13</secondary_id>
    <nct_id>NCT00403767</nct_id>
  </id_info>
  <brief_title>An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation</brief_title>
  <official_title>A Prospective, Randomized, Double-Blind, Parallel-Group, Multicenter, Non-inferiority Study Comparing the Efficacy and Safety of Rivaroxaban (BAY 59-7939) With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Pharmaceutical Research &amp; Development, L.L.C.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Pharmaceutical Research &amp; Development, L.L.C.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy and safety of rivaroxaban with warfarin
      for the prevention of blood clots in the brain (referred to as stroke) and blood clots in
      other parts of the body referred to as non-central nervous system systemic embolism) in
      patients with non-valvular atrial fibrillation (a heart rhythm disorder).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with non-valvular atrial fibrillation who are at risk for stroke and non-central
      nervous system (non-CNS) systemic embolism, will be randomized (assigned by chance) to
      receive treatment with rivaroxaban or warfarin, two different anticoagulants (substances that
      prevent blood clots). Treatment will be double-blinded (neither the patient nor study staff
      will know which study drug is assigned to patients during the study). Patients assigned to
      rivaroxaban will receive rivaroxaban 20 mg orally (p.o.) once daily (OD) plus warfarin
      placebo p.o. OD titrated to a target sham international normalized ratio (INR) of 2.5.
      Patients with moderate renal impairment at screening will receive rivaroxaban 15 mg p.o. OD.
      Patients assigned to warfarin will receive warfarin p.o. OD titrated to a target INR of 2.5
      plus rivaroxaban placebo p.o. OD. The maximum expected length of treatment is up to 32 months
      but may be extended up to 4 years.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Composite Event of Stroke/Non-CNS Systemic Embolism: Primary Efficacy (Non-Inferiority)</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the first occurrence of a stroke or non-CNS systemic embolism while on treatment (defined as the time interval from the first dose to the last dose of study drug plus 2 days). The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Composite of Event of Stroke/Non-CNS Systemic Embolism: Primary Efficacy (Superiority)</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the first occurrence of a stroke or non-CNS systemic embolism while on treatment (defined as the time interval from the first dose to the last dose of study drug plus 2 days). The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Composite Event of Major/Non-major Clinically Relevant Bleeding Events: Primary Safety</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the first occurrence of a major or non-major clinically relevant bleeding event while on treatment. The statistical analysis is based on time from the first dose of study drug to the first occurrence of the event while on treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Composite Event of Stroke/Non-CNS Systemic Embolism/Vascular Death</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the first occurrence of a stroke, non-CNS systemic embolism, or vascular death while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Composite Event of Stroke/Non-CNS Systemic Embolism/Myocardial Infarction/Vascular Death</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the first occurrence of a stroke, non-CNS systemic embolism, myocardial infarction, or vascular death while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Stroke</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the first occurrence of a stroke while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Non-CNS Systemic Embolism</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the first occurrence of a non-CNS systemic embolism while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Myocardial Infarction</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the first occurrence of a myocardial infarction while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Vascular Death</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients with the occurrence of vascular death while on treatment. The statistical analysis is based on time from randomization to the event while on treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause Mortality</measure>
    <time_frame>Up to 4 years</time_frame>
    <description>The number of patients who died due to any cause while on treatment. The statistical analysis is based on time from randomization to the event while on treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14269</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Stroke</condition>
  <condition>Embolism</condition>
  <arm_group>
    <arm_group_label>Rivaroxaban</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Warfarin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivaroxaban</intervention_name>
    <description>Type=exact number, unit=mg, number=20, form=tablet, route=oral use. One 20 mg tablet once daily for an expected maximum treatment period of up to 32 months that may extend up to 4 years (Patients with moderate renal impairment at screening willl have a dose adaptation to rivaroxaban 15 mg, orally, once daily for an expected maximum treatment period of up to 32 months that may extend up to 4 years)</description>
    <arm_group_label>Rivaroxaban</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Warfarin</intervention_name>
    <description>Type=exact number, unit=mg, number=1, 2.5, or 5 mg, form=tablet, route=oral use. Number of warfarin tablets to be determined based on target INR values once daily for an expected maximum treatment period of up to 32 months that may extend up to 4 years</description>
    <arm_group_label>Warfarin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Matching placebo for Rivaroxaban arm (Warfarin placebo)</intervention_name>
    <description>Form=tablet, route=oral. One warfarin placebo tablet taken orally once daily for up to an expected maximum treatment period of 32 months that may extend up to 4 years</description>
    <arm_group_label>Rivaroxaban</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Matching placebo for Warfarin arm (Rivaroxaban placebo)</intervention_name>
    <description>Form-tablet, Route=oral administration. Number of rivaroxaban placebo determined by the number of warfarin tablets taken. Duration of treatment is up to an expected maximum treatment period of 32 months that may extend up to 4 years</description>
    <arm_group_label>Warfarin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must have documented atrial fibrillation on 2 separate occasions within 6
             months before screening

          -  History of a prior stroke, transient ischemic attack or non-neurologic systemic
             embolism believed to be cardiac in origin, or at least two of the following risk
             factors: heart failure, hypertension, age 75 years or greater, diabetes mellitus

        Exclusion Criteria:

          -  Significant mitral stenosis

          -  Transient atrial fibrillation caused by a reversible disorder

          -  Active internal bleeding

          -  Severe disabling stroke

          -  History of intracranial bleeding

          -  Hemorrhagic disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johnson &amp; Johnson Pharmaceutical Research &amp; Development, L.L. C. Clinical Trial</last_name>
    <role>Study Director</role>
    <affiliation>Johnson &amp; Johnson Pharmaceutical Research &amp; Development, L.L.C.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Geneva</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pell City</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Smith</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corona</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fair Oaks</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Healdsburg</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Los Gatos</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Modesto</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orange</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pismo Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Leandro</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Clara</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sylmar</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Yuba City</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pueblo</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Danbury</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guilford</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Debary</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Deerfield Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Walton Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hudson</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Inverness</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Largo</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orange Park</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palm Beach Gardens</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palm Harbor</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Safety Harbor</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tamarac</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albany</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nampa</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aurora</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bannockburn</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Evergreen Park</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fulton</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lombard</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Melrose Park</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moline</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quincy</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rock Island</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Watseka</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anderson</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hammond</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Merrillville</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Muncie</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Munster</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Waterloo</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Crestview Hills</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edgewood</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madisonville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mt Sterling</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lake Charles</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Thibodaux</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vidalia</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Scarborough</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beltsville</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Framingham</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bay City</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bridgman</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chelsea</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dearborn</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mount Clemens</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Petoskey</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Traverse City</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Picayune</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lexington</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anaconda</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beatrice</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pahrump</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bridgewater</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elmer</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Haddon Heights</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paterson</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sewell</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toms River</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wayne</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cortlandt Manor</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>East Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Northport</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saratoga Springs</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Schenectady</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Bern</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Reidsville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rocky Mount</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Minot</city>
        <state>North Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fairfield</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mansfield</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Massillon</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Maumee</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zanesville</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bartlesville</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Midwest City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norman</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Yukon</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jeannette</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jersey Shore</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lansdale</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leetsdale</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lewistown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norristown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>North Wales</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Philipsburg</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Phoenixville</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sayre</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Scranton</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shippensburg</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Topton</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wilkes Barre</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wormleysburg</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wyomissing</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pawtucket</city>
        <state>Rhode Island</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Westerly</city>
        <state>Rhode Island</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Easley</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sumter</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Athens</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Harriman</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lexington</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beaumont</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brownsville</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daingerfield</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Desoto</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Humble</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hurst</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kerrville</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kingwood</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mcallen</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Odessa</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Victoria</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Blacksburg</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chester</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fredericksburg</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Williamsburg</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Port Orchard</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vancouver</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burlington</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elkhorn</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bahia Blanca</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cipolletti</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad Autonoma De Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corrientes</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mar Del Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quilmes</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rosario</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salta</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Martin</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Fe</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tucuman</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Adelaide</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Auchenflower</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bedford Park</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Box Hill</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Caboolture</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cairns</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Camperdown</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chermside</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clayton</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Coffs Harbour</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Footscray</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Garran</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Geelong</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gosford</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Heidelberg Heights</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Herston</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hobart</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Joondalup</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lismore</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liverpool</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miranda</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nedlands</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Lambton Heights</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Parkville</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Penrith</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Prahran</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Reservoir</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Southport</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Windsor</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wolloongabba</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Feldkirch Vorarlberg Vorarlber</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tulln Niederosterreich Niedero</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wien N/A</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wien Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bonheiden</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brasschaat</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brugge</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brussel</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Haine-Saint-Paul</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mol</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nivelles</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ottignies</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roeselare</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seraing</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tienen</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Blumenau</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brasilia</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campina Grande Do Sul</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campinas</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campo Grande</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Curitiba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fortaleza</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goiania</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goinia</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Maceio</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Marilia</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Maringa</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Recife</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rio De Janeiro Br</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rio De Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salvador</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santo Andre</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sao Caetano Do Sul</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sorocaba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>So Jos Do Rio Preto</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>So Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Uberlandia</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dimitrovgrad</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pleven</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Russel</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Veliko Turnovo</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Abbotsford</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burnaby</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campbell River</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Delta</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Langley</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Penticton</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moncton</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. John'S</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sydney</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ajax</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beamsville</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belleville</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corunna</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Courtice</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>E. London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Erie</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kitchener</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Listowel</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Markham</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>North Bay</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>North York</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Parry Sound</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Richmond Hill</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sault Ste Marie</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Scarborough</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Strathroy</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Thornhill</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Whitby</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>York</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicoutimi</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greenfield Park</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Joliette</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jonquiere</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lachine</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Longueuil</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mirabel</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pointe-Claire</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint-Jerome</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint-Lambert</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St-Leonard</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>North Battleford</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arica I Region</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chila</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Concepcin Viii</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Osorno X Region</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Osorno X Regin</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rancagua Vi Region</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Felipe V Region</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santiago De Chile Rm</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santiago Rm</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Temuco Ix</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valdivia X Regin</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Via Del Mar V Regin</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bei Jing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changchun</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changsha</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chengdu</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dalian</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Haikou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hangzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Harbin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jinan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nanjing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Su Zhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Suzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tianjin</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Xian</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barranquilla Atlntico Atlanti</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barranquilla</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bogota D C</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bogota Dc</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bogot Dc Dc</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bogot Dc</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cali Valle Del Cauca</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cali Valley Del Cauca</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Medellin Antioquia</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santander</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brno 2</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chomutov</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hradec Kralove</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Karvin 4</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kutna Hora N/A</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liberec</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Litomysl</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nchod 1</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Olomouc</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ostrava</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pardubice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 10 N/A</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 1</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 2</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 4</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 5</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 8</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Slany</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Svitavy 2</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Svitavy</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Trutnov</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Uhersk Hradist 6</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zln 1</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Esbjerg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Frederiksberg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gentofte</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hellerup</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Helsingr</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hvidovre</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Koege</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kbenhavn</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nstved</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roskilde</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Slagelse</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Viborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jyvskyl N/A</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mikkeli</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albi</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arras</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bayonne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belfort</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Besancon N/A</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bourg En Bresse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bziers Languedoc-Roussillon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Carcassonne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clermont Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corbeil Essonnes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montbeliard</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris Cedex 14</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Perpignan</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint-Brieuc</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St Jean De Verges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Thionville</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Trelivan</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aalen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin/Spandau</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Biberach</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chemnitz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Coburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dachau</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dortmund</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Duisburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ebersbach</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Eilenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Erfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greifswald</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Halle</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hartmannsdorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Henstedt-Rhen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Herford</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Homburg/Saar</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jena</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Julich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kamen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Karlsbad</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kassel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kirchzarten</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Krefeld</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ludwigsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ludwigshafen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lneburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Magdeburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Markkleeberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Meien</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Melsungen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Monchengladbach</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Munchen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mhldorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mlheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mnster</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Neuwied</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nienburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nuernberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paderborn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Potsdam</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Riesa</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rottweil</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sachsen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Siegen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wermsdorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Witten</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wolmirstedt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wuppertal</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Athens Attica</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ioannina</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Maroussi Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Patra</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Piraeus Attica</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tripoli</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Voula Attica</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aberdeen</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hk</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kln</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sha Tin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest N/A</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest Nap</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Debrecen County</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Eger</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gyongyos</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gyr</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kesckemet</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miskolc</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nyiregyhaza</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pecs</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szeged</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szekszard</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szombathely</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Veszprem</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zalaegerszeg</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ahmedabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangalore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bikaner</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chennai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Coimbatore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gandhinagar Guiarat</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hyderabad Andra Pradesh</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jalandhar</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madurai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mangalore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mumbai</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mysore</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pune</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Suraj</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vadodara</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vishakapatnam</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hadera</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nazareth</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Netanya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Petach-Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Petah-Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poriya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Safed</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tel Hashomer</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zerifin</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kyonggi-Do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sungnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Suwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaunas</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Klaipeda</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Panevezys</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Siauliai</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kelantan</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sarawak</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aguascalientes</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad De Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Culiacn Sinaloa/Mxico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guadalajara</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hermosillo</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Monterrey Nuevo Len</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Monterrey</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Queretaro</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Luis Potosi</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sinaloa</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zapopan</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>'S-Gravenhage</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alkmaar</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amersfoort</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Blaricum</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Delft</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Den Bosch</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gc Tilburg</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gouda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Haarlem</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Heerlen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hoofddorp</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hoorn Nh</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leeuwarden</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leidschendam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Meppel</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Schiedam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Veldhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Christchurch</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dunedin</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grafton</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hamilton</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Takapuna Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wellington</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alesund</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elverum</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hamar</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jessheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lillehammer</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moss</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sandefjord</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sandnes</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sandvika</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Skedsmokorset</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>L41 Lima Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lima 1 Lima Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cebuu City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Davao City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Iloilo City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manila City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quezon City</city>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bydgoszcz N/A</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gdansk</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gdynia</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Katowice-Ochojec</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Katowice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Olawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Olsztyn</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Opole</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ostrowiec N/A</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Piotrkow Trybunalski</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Plock</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poznan</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Siedlce</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sieradz N/A</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Skierniewice</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Starogard Gdanski Nap</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szczecin Nap</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szczecin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torun</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa N/A</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wloclawek</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wroclaw N/A</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wroclaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zyrardow N/A</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brasov</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucuresti</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Craiova</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Focsani</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Iasi</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oradea</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sibiu</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Suceava</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tg Mures</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Timisoara</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barnaul</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chelyabinsk Chelyabinsk Region</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chelyabinsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ekaterinburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kemerovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Krasnoyarsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moscow N/A</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nizhni Novgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Novosibirsk Nap</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orenburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Perm</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ryazan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint-Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saratov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Smolensk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tomsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tyumen Tyumen Region</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Yaroslavl Nap</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Yaroslavl</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bloemfontein Free State</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bloemfontein Orange Free State</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cape Town Western Cape</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Centurion Gauteng</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Durban Kwa Zulu Natal</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Johannesburg Gauteng</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kempton Park Gauteng</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Port Elizabeth Eastern Cape</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pretoria Gauteng</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Somerset West Western Cape</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Van Der Bijl Park</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Worcester Western Cape</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>A Coruna</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alicante N/A</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Almeria</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baracaldo Vizcaya</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guadalajara</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Corona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Malaga</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oviedo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palma De Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pamplona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pontevedra</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Sebastin Guipzcoa</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Terrassa</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ljungby</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Skvde</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Basel Bs</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bruderholz</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Geneve</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changhua</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tamshui</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tao-Yuan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangkok Noi</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chiang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pathumthani</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Phathumwan</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ratchatewi</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Adana</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Antalya</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aydin</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Denizli</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Diyarbakir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Eskisehir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grkle</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Izmit</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kayseri</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Konya</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Malatya Nap</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mersin</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Samsun</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cherkassy</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chernigiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dnepropetrovsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dnipropetrovsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Donetsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ivano-Frankivsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kharkiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kirovograd</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kyiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lugansk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lviv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>O1103 Kyiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Odesa</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poltava</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Simferopil</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sumy</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ternopil</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Uzhgorod</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vinnitsya</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vinnytsia</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zaporizhzhya</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zhytomyr</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aberdeen</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belfast</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bournemouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cambridgeshire</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chelmsford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chesterfield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Colchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Craigavon</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Devon</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dundee</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Harrogate</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hull</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lincoln</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Plymouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Romford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sheffield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stirling</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stoke On Trent</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>York</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Caracas</city>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Maracaibo Estado Zulia</city>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Maracay Estado Aragua</city>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Israel</country>
    <country>Korea, Republic of</country>
    <country>Lithuania</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Peru</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
    <country>Venezuela</country>
  </location_countries>
  <removed_countries>
    <country>Belarus</country>
    <country>Italy</country>
    <country>Panama</country>
  </removed_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2006</study_first_submitted>
  <study_first_submitted_qc>November 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2006</study_first_posted>
  <results_first_submitted>December 2, 2011</results_first_submitted>
  <results_first_submitted_qc>June 13, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 17, 2012</results_first_posted>
  <disposition_first_submitted>April 22, 2011</disposition_first_submitted>
  <disposition_first_submitted_qc>April 22, 2011</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">April 29, 2011</disposition_first_posted>
  <last_update_submitted>April 10, 2014</last_update_submitted>
  <last_update_submitted_qc>April 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Stroke</keyword>
  <keyword>Embolism</keyword>
  <keyword>Non-central nervous system systemic embolism</keyword>
  <keyword>Non-valvular atrial fibrillation</keyword>
  <keyword>Blood Clot</keyword>
  <keyword>Rivaroxaban</keyword>
  <keyword>Warfarin</keyword>
  <keyword>Anticoagulants</keyword>
  <keyword>Arrhythmias, Cardiac</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Warfarin</mesh_term>
    <mesh_term>Rivaroxaban</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study, an efficacy and safety study of Rivaroxaban with Warfarin for the prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation, was conducted from 18 December 2006 to 07 September 2010. Patients were recruited at 1,170 study centers located in 45 countries worldwide.</recruitment_details>
      <pre_assignment_details>A total of 14,269 patients were randomized in the study. Five patients were randomized twice bringing the number of randomized unique patients to 14,264. A total of 14,236 (7111 and 7125 patients in the rivaroxaban and warfarin groups, respectively) unique patients took at least 1 dose of study medication and were included in the Safety Population.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Rivaroxaban</title>
          <description>Rivaroxaban 15 mg p.o. once daily or Rivaroxaban 20 mg p.o. once daily</description>
        </group>
        <group group_id="P2">
          <title>Warfarin</title>
          <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7111"/>
                <participants group_id="P2" count="7125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4591"/>
                <participants group_id="P2" count="4657"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2520"/>
                <participants group_id="P2" count="2468"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="993"/>
                <participants group_id="P2" count="919"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-compliant with study medication</title>
              <participants_list>
                <participants group_id="P1" count="134"/>
                <participants group_id="P2" count="164"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Consent withdrawn</title>
              <participants_list>
                <participants group_id="P1" count="671"/>
                <participants group_id="P2" count="673"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Investigator dec./not protocol-related</title>
              <participants_list>
                <participants group_id="P1" count="191"/>
                <participants group_id="P2" count="178"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="142"/>
                <participants group_id="P2" count="124"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Clinical efficacy endpoint reached</title>
              <participants_list>
                <participants group_id="P1" count="300"/>
                <participants group_id="P2" count="332"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study terminated by sponsor</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing/incomplete data</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Rivaroxaban</title>
          <description>Rivaroxaban 15 mg p.o. once daily or Rivaroxaban 20 mg p.o. once daily</description>
        </group>
        <group group_id="B2">
          <title>Warfarin</title>
          <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7111"/>
            <count group_id="B2" value="7125"/>
            <count group_id="B3" value="14236"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1646"/>
                    <measurement group_id="B2" value="1642"/>
                    <measurement group_id="B3" value="3288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5465"/>
                    <measurement group_id="B2" value="5483"/>
                    <measurement group_id="B3" value="10948"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age Continuous</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71.2" spread="9.45"/>
                    <measurement group_id="B2" value="71.2" spread="9.39"/>
                    <measurement group_id="B3" value="71.2" spread="9.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2819"/>
                    <measurement group_id="B2" value="2826"/>
                    <measurement group_id="B3" value="5645"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4292"/>
                    <measurement group_id="B2" value="4299"/>
                    <measurement group_id="B3" value="8591"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Argentina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="284"/>
                    <measurement group_id="B2" value="285"/>
                    <measurement group_id="B3" value="569"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                    <measurement group_id="B2" value="122"/>
                    <measurement group_id="B3" value="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Belgium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="241"/>
                    <measurement group_id="B2" value="242"/>
                    <measurement group_id="B3" value="483"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bulgaria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="337"/>
                    <measurement group_id="B2" value="339"/>
                    <measurement group_id="B3" value="676"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="372"/>
                    <measurement group_id="B2" value="375"/>
                    <measurement group_id="B3" value="747"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chile</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144"/>
                    <measurement group_id="B2" value="142"/>
                    <measurement group_id="B3" value="286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="249"/>
                    <measurement group_id="B2" value="246"/>
                    <measurement group_id="B3" value="495"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Colombia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="134"/>
                    <measurement group_id="B2" value="133"/>
                    <measurement group_id="B3" value="267"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Czech Republic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="299"/>
                    <measurement group_id="B2" value="299"/>
                    <measurement group_id="B3" value="598"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="263"/>
                    <measurement group_id="B2" value="265"/>
                    <measurement group_id="B3" value="528"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Greece</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hungary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="118"/>
                    <measurement group_id="B3" value="237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>India</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="133"/>
                    <measurement group_id="B2" value="135"/>
                    <measurement group_id="B3" value="268"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="94"/>
                    <measurement group_id="B3" value="188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Korea (South)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lithuania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="122"/>
                    <measurement group_id="B2" value="122"/>
                    <measurement group_id="B3" value="244"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malaysia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mexico</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Netherlands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Zealand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peru</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Philippines</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="185"/>
                    <measurement group_id="B2" value="183"/>
                    <measurement group_id="B3" value="368"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="263"/>
                    <measurement group_id="B2" value="264"/>
                    <measurement group_id="B3" value="527"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Romania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="391"/>
                    <measurement group_id="B2" value="391"/>
                    <measurement group_id="B3" value="782"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Russia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="645"/>
                    <measurement group_id="B2" value="645"/>
                    <measurement group_id="B3" value="1290"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Singapore</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>South Africa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="122"/>
                    <measurement group_id="B2" value="125"/>
                    <measurement group_id="B3" value="247"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="124"/>
                    <measurement group_id="B3" value="248"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Taiwan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thailand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Turkey</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ukraine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="505"/>
                    <measurement group_id="B2" value="504"/>
                    <measurement group_id="B3" value="1009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="159"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="962"/>
                    <measurement group_id="B2" value="964"/>
                    <measurement group_id="B3" value="1926"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Venezuela</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hong Kong</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Composite Event of Stroke/Non-CNS Systemic Embolism: Primary Efficacy (Non-Inferiority)</title>
        <description>The number of patients with the first occurrence of a stroke or non-CNS systemic embolism while on treatment (defined as the time interval from the first dose to the last dose of study drug plus 2 days). The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The per-protocol (PP) population consisted of all randomized unique patients excluding those who had specific pre-defined major protocol deviations that occurred by the time of enrollment into the study or during the trial. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Composite Event of Stroke/Non-CNS Systemic Embolism: Primary Efficacy (Non-Inferiority)</title>
          <description>The number of patients with the first occurrence of a stroke or non-CNS systemic embolism while on treatment (defined as the time interval from the first dose to the last dose of study drug plus 2 days). The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
          <population>The per-protocol (PP) population consisted of all randomized unique patients excluding those who had specific pre-defined major protocol deviations that occurred by the time of enrollment into the study or during the trial. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6958"/>
                <count group_id="O2" value="7004"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="188"/>
                    <measurement group_id="O2" value="241"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Alternative hypothesis of non-inferiority (NI) by a NI margin of 1.46 in hazard ratio (HR) based on on-treatment data from the per protocol population. The required number of primary efficacy endpoint events was determined based on the following assumptions: NI margin of 1.46, 1-sided alpha of 0.025, power of &gt;95% when true HR is 1, and exponential distributions. The margin was selected based on clinical appropriateness and quantitative analysis of relevant studies in Hart et al.</non_inferiority_desc>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>The p-value is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.025 (1-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Composite of Event of Stroke/Non-CNS Systemic Embolism: Primary Efficacy (Superiority)</title>
        <description>The number of patients with the first occurrence of a stroke or non-CNS systemic embolism while on treatment (defined as the time interval from the first dose to the last dose of study drug plus 2 days). The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Composite of Event of Stroke/Non-CNS Systemic Embolism: Primary Efficacy (Superiority)</title>
          <description>The number of patients with the first occurrence of a stroke or non-CNS systemic embolism while on treatment (defined as the time interval from the first dose to the last dose of study drug plus 2 days). The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7061"/>
                <count group_id="O2" value="7082"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="189"/>
                    <measurement group_id="O2" value="243"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.015</p_value>
            <p_value_desc>The p-value Is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.65</ci_lower_limit>
            <ci_upper_limit>0.95</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Composite Event of Major/Non-major Clinically Relevant Bleeding Events: Primary Safety</title>
        <description>The number of patients with the first occurrence of a major or non-major clinically relevant bleeding event while on treatment. The statistical analysis is based on time from the first dose of study drug to the first occurrence of the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Composite Event of Major/Non-major Clinically Relevant Bleeding Events: Primary Safety</title>
          <description>The number of patients with the first occurrence of a major or non-major clinically relevant bleeding event while on treatment. The statistical analysis is based on time from the first dose of study drug to the first occurrence of the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7111"/>
                <count group_id="O2" value="7125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1475"/>
                    <measurement group_id="O2" value="1449"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternate hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.442</p_value>
            <p_value_desc>The p-value is not adjusted for mulitple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as a covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.96</ci_lower_limit>
            <ci_upper_limit>1.11</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Composite Event of Stroke/Non-CNS Systemic Embolism/Vascular Death</title>
        <description>The number of patients with the first occurrence of a stroke, non-CNS systemic embolism, or vascular death while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Composite Event of Stroke/Non-CNS Systemic Embolism/Vascular Death</title>
          <description>The number of patients with the first occurrence of a stroke, non-CNS systemic embolism, or vascular death while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7061"/>
                <count group_id="O2" value="7125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="346"/>
                    <measurement group_id="O2" value="410"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.034</p_value>
            <p_value_desc>The p-value is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.86</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Composite Event of Stroke/Non-CNS Systemic Embolism/Myocardial Infarction/Vascular Death</title>
        <description>The number of patients with the first occurrence of a stroke, non-CNS systemic embolism, myocardial infarction, or vascular death while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Composite Event of Stroke/Non-CNS Systemic Embolism/Myocardial Infarction/Vascular Death</title>
          <description>The number of patients with the first occurrence of a stroke, non-CNS systemic embolism, myocardial infarction, or vascular death while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7061"/>
                <count group_id="O2" value="7082"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="433"/>
                    <measurement group_id="O2" value="519"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.010</p_value>
            <p_value_desc>The p-value is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Stroke</title>
        <description>The number of patients with the first occurrence of a stroke while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Stroke</title>
          <description>The number of patients with the first occurrence of a stroke while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7061"/>
                <count group_id="O2" value="7082"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="184"/>
                    <measurement group_id="O2" value="221"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.092</p_value>
            <p_value_desc>The p-value is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as a covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.70</ci_lower_limit>
            <ci_upper_limit>1.03</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Non-CNS Systemic Embolism</title>
        <description>The number of patients with the first occurrence of a non-CNS systemic embolism while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Non-CNS Systemic Embolism</title>
          <description>The number of patients with the first occurrence of a non-CNS systemic embolism while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7061"/>
                <count group_id="O2" value="7082"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <p_value_desc>The p-value is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.23</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.09</ci_lower_limit>
            <ci_upper_limit>0.61</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Myocardial Infarction</title>
        <description>The number of patients with the first occurrence of a myocardial infarction while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Myocardial Infarction</title>
          <description>The number of patients with the first occurrence of a myocardial infarction while on treatment. The statistical analysis is based on time from randomization to the first occurrence of the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7061"/>
                <count group_id="O2" value="7082"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                    <measurement group_id="O2" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.121</p_value>
            <p_value_desc>The p-value is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as a covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.81</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.63</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Vascular Death</title>
        <description>The number of patients with the occurrence of vascular death while on treatment. The statistical analysis is based on time from randomization to the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>The Individual Components of the Composite Primary and Major Secondary Efficacy Outcome Measures: Vascular Death</title>
          <description>The number of patients with the occurrence of vascular death while on treatment. The statistical analysis is based on time from randomization to the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7061"/>
                <count group_id="O2" value="7082"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="170"/>
                    <measurement group_id="O2" value="193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.289</p_value>
            <p_value_desc>The p-value is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as a covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.89</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.73</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All-cause Mortality</title>
        <description>The number of patients who died due to any cause while on treatment. The statistical analysis is based on time from randomization to the event while on treatment.</description>
        <time_frame>Up to 4 years</time_frame>
        <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban</title>
            <description>Rivaroxaban 20 mg p.o. once daily or matching placebo (15 mg p.o. once daily for patients with a calculated creatinine clearance of 30  49 mL/min. at baseline)</description>
          </group>
          <group group_id="O2">
            <title>Warfarin</title>
            <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause Mortality</title>
          <description>The number of patients who died due to any cause while on treatment. The statistical analysis is based on time from randomization to the event while on treatment.</description>
          <population>The safety population consisted of all randomized unique patients who took at least 1 dose of study medication after randomization during the double-blind treatment period. Site 042012 with GCP violation was excluded.</population>
          <units>Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7061"/>
                <count group_id="O2" value="7125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="208"/>
                    <measurement group_id="O2" value="250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis of superiority based on on-treatment data from the safety population.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.073</p_value>
            <p_value_desc>The p-value is not adjusted for multiple comparisons. The alpha threshold for statistical significance is 0.05 (2-sided).</p_value_desc>
            <method>Cox Proportional Hazards model</method>
            <method_desc>(non-stratified) Cox Proportional Hazards model with treatment as covariate</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.70</ci_lower_limit>
            <ci_upper_limit>1.02</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Rivaroxaban</title>
          <description>Rivaroxaban 15 mg p.o. once daily or Rivaroxaban 20 mg p.o. once daily</description>
        </group>
        <group group_id="E2">
          <title>Warfarin</title>
          <description>Warfarin (1 mg, 2.5 mg, or 5 mg p.o. once daily)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>13.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2649" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2720" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="68" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anaemia Haemolytic Autoimmune</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anaemia Vitamin B12 Deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anaemia of Malignant Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Febrile Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemolytic Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypochromic Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypocoagulable State</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypoplastic Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Idiopathic Thrombocytopenic Purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Microcytic Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nephrogenic Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Normochromic Normocytic Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Polycythaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Splenic Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thrombocytopenic Purpura</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anaemia Macrocytic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Disseminated Intravascular Coagulation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Splenic Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Coronary Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Acute Left Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Acute Right Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Adams-Stokes Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Angina Unstable</sub_title>
                <counts group_id="E1" subjects_affected="74" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="92" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Valve Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Valve Disease Mixed</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Valve Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis Coronary Artery</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="158" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="161" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Atrial Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Atrial Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Complete</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Second Degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Asthma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" subjects_affected="283" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="309" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Acute</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Chronic</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" subjects_affected="178" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="206" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardio-Respiratory Arrest</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary Failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiovascular Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Congestive Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cor Pulmonale</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Coronary Artery Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Coronary Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Electromechanical Dissociation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Heart Valve Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypertensive Heart Disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypertrophic Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ischaemic Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Left Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Left Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mitral Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Myocardial Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Myocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nodal Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nodal Rhythm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pericardial Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Right Ventricular Failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sick Sinus Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sinus Arrest</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sinus Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sinus Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Supraventricular Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tachycardia Paroxysmal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Torsade De Pointes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ventricular Asystole</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ventricular Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ventricular Tachyarrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chronotropic Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mitral Valve Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mitral Valve Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tricuspid Valve Incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Angiodysplasia Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pyloric Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>External Ear Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Inner Ear Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Meniere's Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sudden Hearing Loss</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vertigo Positional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vestibular Disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>External Ear Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Cushing's Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Primary Hyperaldosteronism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis Fugax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Angle Closure Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cataract Diabetic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chorioretinal Atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Conjunctival Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dacryostenosis Acquired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Eye Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Glaucomatocyclitic Crises</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hyphaema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Keratopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Macular Degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Macular Hole</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Macular Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Open Angle Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retinal Artery Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retinal Detachment</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retinal Vein Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retinal Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retinopathy Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retinoschisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Scleral Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Strabismus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ulcerative Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vitreous Degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vitreous Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Adhesions</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Hernia Obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Strangulated Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Wall Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Acute Abdomen</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anal Fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colitis Ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colitis Ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colonic Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colonic Polyp</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dental Caries</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diverticular Perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diverticulitis Intestinal Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diverticulum Intestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diverticulum Intestinal Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Duodenal Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Enterocolitis Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Faeces Discoloured</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Femoral Hernia, Obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Food Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Polyps</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Varices</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Varices Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastritis Erosive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastritis Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastroduodenal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastroduodenal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="88" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Motility Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrooesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gingival Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Erosive Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hiatus Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ileus Paralytic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Inflammatory Bowel Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia Strangulated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia, Obstructive</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Dilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intestinal Strangulation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intra-Abdominal Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intra-Abdominal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Irritable Bowel Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Large Intestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Large Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Large Intestine Perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lower Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lumbar Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mechanical Ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mesenteric Artery Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mesenteric Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mouth Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Spasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Varices Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophagitis Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatic Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatic Mass</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatitis Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatitis Relapsing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peritoneal Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rectal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rectal Polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rectal Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rectal Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Regurgitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retroperitoneal Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retroperitoneal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Small Intestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tongue Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Umbilical Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Umbilical Hernia, Obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Upper Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Varices Oesophageal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anal Fissure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Barrett's Oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Erosive Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatitis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peritoneal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Small Intestinal Perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Catheter Site Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chest Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="44" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Device Capturing Issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Device Dislocation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Device Lead Damage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Device Malfunction</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Device Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Device Power Source Issue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gait Disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>General Physical Health Deterioration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Generalised Oedema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hernia Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Impaired Healing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Implant Site Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Implant Site Reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Injury Associated with Device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Medical Device Complication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Multi-Organ Failure</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pelvic Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sudden Cardiac Death</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sudden Death</sub_title>
                <counts group_id="E1" subjects_affected="80" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Systemic Inflammatory Response Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thrombosis in Device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vessel Puncture Site Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Feeling Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Implant Site Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mucosal Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile Duct Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bile Duct Stone</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Biliary Colic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholangitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholangitis Sclerosing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholecystitis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholelithiasis Obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cryptogenic Cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cytolytic Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gallbladder Fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Function Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Steatosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatitis Acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ischaemic Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Jaundice Cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Jaundice Hepatocellular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Liver Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Portal Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Acute Hepatic Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Hepatic Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anaphylactic Shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Graft Rejection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abscess Limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abscess Neck</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abscess of External Auditory Meatus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Amoebiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Amoebic Dysentery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Appendiceal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Appendicitis Perforated</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arthritis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arthritis Infective</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bacterial Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bacterial Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bacterial Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blister Infected</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Breast Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bronchitis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bronchitis Viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bursitis Infective Staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="64" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cellulitis Pharyngeal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cellulitis of Male External Genital Organ</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cervicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cholecystitis Infective</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Clostridial Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dengue Fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Device Related Infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Foot Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diarrhoea Infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ear Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Encephalitis Herpes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Endocarditis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Enterococcal Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Escherichia Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Extradural Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Norovirus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Salmonella</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Groin Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haematoma Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Helicobacter Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatitis E</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatitis Viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Herpes Zoster</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Herpes Zoster Ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Herpes Zoster Oticus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Implant Site Infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Incision Site Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Infected Epidermal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Infected Sebaceous Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Infected Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Infective Exacerbation of Chronic Obstructive Airways Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Infusion Site Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intertrigo Candida</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intervertebral Discitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Kidney Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Laryngitis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Leptospirosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Liver Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lobar Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Localised Infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection Viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Infection</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Infection Pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lyme Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Malaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Meningitis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Meningitis Pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Meningitis Viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nasal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neuroborreliosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Otitis Externa</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Otitis Media</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Otitis Media Chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pelvic Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peridiverticular Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Perihepatic Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Perirectal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peritoneal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peritonsillar Abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Periumbilical Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumococcal Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="157" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="197" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumonia Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumonia Pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumonia Staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Post Procedural Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Post Procedural Infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pyelonephritis Acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pyelonephritis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pyoderma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pyothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rectal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Salmonellosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Scrotal Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Bacterial Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Staphylococcal Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Streptococcal Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Streptococcal Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Subacute Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Subcutaneous Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Syphilis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tooth Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tuberculous Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection Staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vestibular Neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Viral Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Viral Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>West Nile Viral Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Wound Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Clostridium Difficile Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Febrile Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemophilus Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Necrotising Fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neutropenic Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pharyngeal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pseudomembranous Colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sepsis Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Accidental Overdose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Alcohol Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Avulsion Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Back Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Brain Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Burns Third Degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Carbon Monoxide Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cervical Vertebral Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chest Injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Clavicle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Compression Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Drug Toxicity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Extradural Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Face Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Facial Bones Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Femoral Neck Fracture</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Fibula Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Foot Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gun Shot Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hand Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Head Injury</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>In-Stent Coronary Artery Restenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Incision Site Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Incisional Hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Joint Dislocation</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Joint Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Limb Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lower Limb Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lumbar Vertebral Fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Meniscus Lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Multiple Fractures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Multiple Injuries</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Muscle Rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Muscle Strain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neck Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Operative Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Patella Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pelvic Fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Periorbital Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Post Procedural Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Post Procedural Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Postoperative Respiratory Distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Procedural Complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pubis Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Radius Fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Road Traffic Accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skeletal Injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skull Fractured Base</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Soft Tissue Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Spinal Column Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Spinal Compression Fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Spinal Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Splenic Rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Subcutaneous Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Subdural Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Subdural Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tendon Rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Therapeutic Agent Toxicity</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thoracic Vertebral Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tibia Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Traumatic Brain Injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Traumatic Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Traumatic Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Traumatic Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Traumatic Intracranial Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Upper Limb Fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vascular Graft Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vascular Pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Wound Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Wrist Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Function Disturbance Postoperative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Eschar</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Foreign Body</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nerve Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Traumatic Lung Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Venous Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine Aminotransferase Increased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arteriogram</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arteriogram Coronary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aspartate Aminotransferase Increased</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bilirubin Conjugated Increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blood Alkaline Phosphatase Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blood Amylase Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blood Bilirubin Increased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blood Glucose Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blood Potassium Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blood Pressure Increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>C-Reactive Protein Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chest X-Ray Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Coagulation Time Prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dexamethasone Suppression Test Positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ejection Fraction Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemoglobin Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Heart Rate Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Heart Rate Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Heart Rate Irregular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Enzyme Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Enzyme Increased</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Increased</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intraocular Pressure Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Laboratory Test Interference</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lipase Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Liver Function Test Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Occult Blood</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Occult Blood Positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatic Enzymes Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Transaminases Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Weight Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aspiration Bronchial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prothrombin Level Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prothrombin Time Prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Decreased Appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus Inadequate Control</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Foot</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemochromatosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hyperosmolar State</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypoproteinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neuroglycopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Podagra</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Shock Hypoglycaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Type 1 Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Type 2 Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vitamin B12 Deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Failure to Thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bone Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Coccydynia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Compartment Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dupuytren's Contracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Fracture Nonunion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gouty Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Groin Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Inguinal Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Degeneration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Protrusion</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Jaw Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Joint Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Joint Range of Motion Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Knee Deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mobility Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Monarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Muscle Atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Muscle Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Muscle Spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neuropathic Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pathological Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Periostitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Polymyalgia Rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Psoriatic Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rheumatoid Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rotator Cuff Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Soft Tissue Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Spinal Column Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Spinal Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Spinal Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sympathetic Posterior Cervical Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Synovial Cyst</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Systemic Lupus Erythematosus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Trismus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pain in Extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Trigger Finger</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Adrenal Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>B-Cell Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Basal Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Benign Colonic Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Benign Neoplasm of Bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Benign Neoplasm of Prostate</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bile Duct Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bladder Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bladder Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bladder Papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bladder Transitional Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bone Sarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bowen's Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Brain Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Brain Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Brain Neoplasm Benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Breast Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Breast Cancer in Situ</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Breast Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bronchial Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cervix Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colon Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colon Cancer</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colon Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colon Cancer Recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colon Cancer Stage Iii</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colon Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colorectal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Endometrial Cancer</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Endometrial Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Epiglottic Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gallbladder Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Cancer</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Cancer Stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Cancer Stage Iv</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Glioblastoma Multiforme</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Glioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Neoplasm Malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Infected Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intra-Abdominal Haemangioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intracranial Tumour Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Large Cell Carcinoma of the Respiratory Tract Stage Unspecified</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Laryngeal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma Recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lentigo Maligna Stage Unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lip And/Or Oral Cavity Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Liposarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Adenocarcinoma Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Carcinoma Cell Type Unspecified Stage Iv</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Neoplasm Malignant</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Squamous Cell Carcinoma Stage Unspecified</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Malignant Melanoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Malignant Palate Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Malignant Urinary Tract Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mesothelioma Malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastases to Central Nervous System</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastases to Liver</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastases to Lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastatic Bronchial Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastatic Carcinoma of the Bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastatic Malignant Melanoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastatic Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Multiple Myeloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Myelodysplastic Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Myeloproliferative Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neoplasm Malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neoplasm Prostate</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neurilemmoma Malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neuroendocrine Carcinoma of the Skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's Lymphoma Recurrent</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Non-Small Cell Lung Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ovarian Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ovarian Fibroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ovarian Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pancreatic Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Paraneoplastic Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pituitary Tumour Benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Polycythaemia Vera</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostate Cancer</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostate Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostate Cancer Recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostatic Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rectal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rectal Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Salivary Gland Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Salivary Gland Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Small Cell Lung Cancer Stage Unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Small Intestine Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma of Skin</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Testis Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Throat Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thyroid Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thyroid Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thyroid Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Transitional Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ureteric Cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ureteric Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Uterine Cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vulval Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Pancreas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Benign Soft Tissue Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colon Cancer Stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colon Cancer Stage Iv</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastric Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Stromal Tumour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lymphangiosis Carcinomatosa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mediastinum Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metastases to Bone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neoplasm Skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oesophageal Squamous Cell Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rectal Cancer Stage Iii</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Refractory Anaemia with An Excess of Blasts</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Retroperitoneal Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ureteral Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Anoxic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Balance Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Basal Ganglia Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Brachial Plexopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Brain Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Brain Stem Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Carotid Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Carotid Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Carotid Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Carotid Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cauda Equina Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Central Pain Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebellar Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebral Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebral Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebral Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebral Infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebral Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cervicobrachial Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chorea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Clonic Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cognitive Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Complex Partial Seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's Type</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Autonomic Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dyskinesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Facial Palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Facial Paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Grand Mal Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhage Intracranial</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Cerebral Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Transformation Stroke</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hepatic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypertensive Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic Coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypotonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypoxic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Iiird Nerve Paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intercostal Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intracranial Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intracranial Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intraventricular Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ischaemic Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ischaemic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lacunar Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Loss of Consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lumbar Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metabolic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Myasthenia Gravis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nerve Compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neuropathy Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Parkinson's Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Parkinsonism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Partial Seizures</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Partial Seizures with Secondary Generalisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Petit Mal Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Postictal Paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Radicular Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Radiculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Radiculitis Lumbosacral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Senile Dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sensory Disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Simple Partial Seizures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Status Epilepticus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Subarachnoid Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Toxic Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Transient Global Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" subjects_affected="50" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vascular Dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vascular Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vith Nerve Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cerebellar Atrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Hyperosmolar Coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Embolic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Paraplegia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Cephalhaematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Psychosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Alcohol Abuse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Completed Suicide</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Generalised Anxiety Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hallucination, Visual</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mental Disorder Due to A General Medical Condition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mental Status Changes</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mood Disorder Due to A General Medical Condition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Neurosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Panic Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Post-Traumatic Stress Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Psychotic Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Suicide Attempt</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bipolar Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Prerenal Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bladder Neck Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bladder Prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Calculus Bladder</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Calculus Ureteric</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Calculus Urethral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Calculus Urinary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cystitis Erosive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cystitis Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Focal Segmental Glomerulosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="62" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhage Urinary Tract</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypertensive Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Kidney Enlargement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nephropathy Toxic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nephrotic Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Obstructive Uropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Artery Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Artery Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Failure Chronic</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Renal Impairment</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ureteric Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urethral Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urethral Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urinary Bladder Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urinary Bladder Polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urinary Tract Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urogenital Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Endometrial Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Endometrial Hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Erectile Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Female Genital Tract Fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Genital Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Ovarian Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Oedema Genital</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Postmenopausal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostatic Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Scrotal Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Uterine Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Uterine Polyp</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Uterine Prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vaginal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vulval Ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Fibrocystic Breast Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostatic Atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostatic Intraepithelial Neoplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Distress Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Brain Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bronchitis Chronic</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Choking</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="56" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Chronic Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diaphragmatic Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dyspnoea Exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Foreign Body Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Interstitial Lung Disease</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Laryngeal Polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lung Disorder</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Mediastinal Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nasal Polyps</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nasal Septum Deviation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Paranasal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pharyngeal Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pleuritic Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Arterial Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Microemboli</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Respiratory Arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Respiratory Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Respiratory Distress</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Sleep Apnoea Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Status Asthmaticus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Blood Blister</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dermal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dermatitis Allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dermatitis Atopic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Dry Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Erythema Multiforme</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Leukocytoclastic Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Panniculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prurigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Seborrhoeic Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Stevens-Johnson Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Umbilical Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Urticaria Chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Decubitus Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cardiac Pacemaker Battery Replacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Pacemaker Insertion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Pacemaker Replacement</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardiac Pacemaker Revision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cardioversion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Decompression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cataract Operation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Finger Amputation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Foot Amputation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhoid Operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hip Arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Implantable Defibrillator Insertion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia Repair</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Knee Arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Knee Operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Limb Operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Penile Repair</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Percutaneous Coronary Intervention</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Polypectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Prostatectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Graft</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Skin Neoplasm Excision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Tooth Extraction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Transurethral Prostatectomy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Varicose Vein Operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Wound Drainage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Abdominal Hernia Repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Colostomy Closure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Ileostomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Malignant Tumour Excision</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Angiopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Aneurysm Rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Dilatation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Aortic Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arterial Stenosis Limb</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arterial Thrombosis Limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis Obliterans</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Arteriovenous Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Bleeding Varicose Vein</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Circulatory Collapse</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diabetic Vascular Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Diastolic Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Essential Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Extremity Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Femoral Arterial Stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Femoral Artery Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemodynamic Instability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypertensive Emergency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Hypovolaemic Shock</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Intermittent Claudication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Jugular Vein Distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Microangiopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peripheral Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorder</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Raynaud's Phenomenon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Shock Haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis Migrans</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis Superficial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Varicose Ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Varicose Vein</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vasculitis Necrotising</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Venous Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Venous Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Venous Thrombosis Limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Lymphatic Fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Subclavian Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Vena Cava Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>13.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2537" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="2573" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="384" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="401" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="443" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="451" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="377" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="401" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="430" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="464" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="445" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="453" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="332" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="367" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="389" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="382" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="705" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="594" subjects_at_risk="7125"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="356" subjects_at_risk="7111"/>
                <counts group_id="E2" subjects_affected="363" subjects_at_risk="7125"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Head of Development, CV &amp; UROL</name_or_title>
      <organization>Johnson &amp; Johnson Pharmaceutical Research &amp; Development L.L.C.</organization>
      <phone>1 908-927-7767</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

